Abstract
The influence of androgen receptor (AR) GGC repeat polymorphism on the metabolic profile of men has been much less studied than the one of CAG tract polymorphism. Therefore, in this study, we looked for the association of GGC and CAG tract with cardiovascular risk factors in men. Ninety-eight men followed by our andrological unit were retrospectively reviewed. Clinical and biochemical parameters on cardiovascular risk were considered. AR CAG and GGC polymorphisms were studied. GGC triplets were found to be positively and significantly correlated with several cardiovascular risk factors. On the other hand, inverse and significant correlations of CAG triplets were found with insulin and HOMA. As expected, age was positively correlated with cardiovascular risk, whereas total testosterone was inversely correlated with metabolic profile. Estradiol was not found to be correlated with any of the metabolic parameters. In the total sample, multivariate linear regression analysis confirms the positive and independent association of GGC triplets with glycemia, glycated hemoglobin, total cholesterol, triglycerides and homeostasis model assessment of insulin resistance (HOMA), whereas CAG repeat length is negatively associated with insulin and HOMA. Such associations are also substantially confirmed in non-diabetic subjects, whereas in diabetic patients only the GGC tract seems to be involved in the metabolic profile regulation. Our work shows a relevant role for GGC repeat tract in conditioning male cardiovascular risk, thus rendering necessary a deeper analysis on the role of GGC polymorphism both from the molecular and the clinical point of view.
Similar content being viewed by others
References
Tirabassi G, Gioia A, Giovannini L, Boscaro M, Corona G, Carpi A, Maggi M, Balercia G (2013) Testosterone and cardiovascular risk. Intern Emerg Med 8(Suppl 1):S65–S69
Rosano GM, Vitale C, Fini M (2015) Testosterone in men with hypogonadism and high cardiovascular risk. Pros Endocrine 50:320–325
Iglesias P, Prado F, Muñoz A, Guerrero MT, Macías MC, Ridruejo E, Tajada P, García-Arévalo C, Díez JJ (2015) Natural course of hypogonadism diagnosed during hospitalization in aged male patients. Endocrine 48:978–984
Bekaert M, Van Nieuwenhove Y, Calders P, Cuvelier CA, Batens AH, Kaufman JM, Ouwens DM, Ruige JB (2015) Determinants of testosterone levels in human male obesity. Endocrine 50:202–211
Buysschaert M, Medina JL, Bergman M, Shah A, Lonier J (2015) Prediabetes and associated disorders. Endocrine 48:371–393
Mitsuhashi K, Senmaru T, Fukuda T, Yamazaki M, Shinomiya K, Ueno M, Kinoshita S, Kitawaki J, Katsuyama M, Tsujikawa M, Obayashi H, Nakamura N, Fukui M (2016) Testosterone stimulates glucose uptake and GLUT4 translocation through LKB1/AMPK signaling in 3T3-L1 adipocytes. Endocrine 51:174–184
Tirabassi G, Delli Muti N, Corona G, Maggi M, Balercia G (2013) Androgen receptor gene CAG repeat polymorphism regulates the metabolic effects of testosterone replacement therapy in male postsurgical hypogonadotropic hypogonadism. Int J Endocrinol 2013:816740
Ding D, Xu L, Menon M, Reddy GP, Barrack ER (2005) Effect of GGC (glycine) repeat length polymorphism in the human androgen receptor on androgen action. Prostate 62:133–139
Tirabassi G, Biagioli A, Balercia G (2014) Bone benefits of testosterone replacement therapy in male hypogonadism. Panminerva Med 56:151–163
Tirabassi G, Cignarelli A, Perrini S, Delli Muti N, Furlani G, Gallo M, Pallotti F, Paoli D, Giorgino F, Lombardo F, Gandini L, Lenzi A, Balercia G (2015) Influence of CAG repeat polymorphism on the targets of testosterone action. Int J Endocrinol 2015:298107
Tirabassi G, Delli Muti N, Corona G, Maggi M, Balercia G (2014) Androgen receptor gene CAG repeat polymorphism independently influences recovery of male sexual function after testosterone replacement therapy in postsurgical hypogonadotropic hypogonadism. J Sex Med 11:1302–1308
Delli Muti N, Tirabassi G, Buldreghini E, Lenzi A, Balercia G (2014) Synergistic effect of androgen receptor (CAG repeat length) and endothelial nitric oxide synthase (Glu298Asp variant) gene polymorphisms on seminal parameters in men with idiopathic oligoasthenozoospermia. Endocrine 47:322–324
Tirabassi G, Delli Muti N, Buldreghini E, Lenzi A, Balercia G (2014) Central body fat changes in men affected by post-surgical hypogonadotropic hypogonadism undergoing testosterone replacement therapy are modulated by androgen receptor CAG polymorphism. Nutr Metab Cardiovasc Dis 24:908–913
Stanworth RD, Kapoor D, Channer KS, Jones TH (2011) Dyslipidaemia is associated with testosterone, oestradiol and androgen receptor CAG repeat polymorphism in men with type 2 diabetes. Clin Endocrinol (Oxf) 74:624–630
Goutou M, Sakka C, Stakias N, Stefanidis I, Koukoulis GN (2009) AR CAG repeat length is not associated with serum gonadal steroids and lipid levels in healthy men. Int J Androl 32:616–622
Hersberger M, Muntwyler J, Funke H, Marti-Jaun J, Schulte H, Assmann G, Lüscher TF, von Eckardstein A (2005) The CAG repeat polymorphism in the androgen receptor gene is associated with HDL-cholesterol but not with coronary atherosclerosis or myocardial infarction. Clin Chem 51:1110–1115
Zitzmann M, Brune M, Kornmann B, Gromoll J, von Eckardstein S, von Eckardstein A, Nieschlag E (2001) The CAG repeat polymorphism in the AR gene affects high density lipoprotein cholesterol and arterial vasoreactivity. J Clin Endocrinol Metab 86:4867–4873
Pausova Z, Abrahamowicz M, Mahboubi A, Syme C, Leonard GT, Perron M, Richer L, Veillette S, Gaudet D, Paus T (2010) Functional variation in the androgen-receptor gene is associated with visceral adiposity and blood pressure in male adolescents. Hypertension 55:706–714
Alevizaki M, Cimponeriu AT, Garofallaki M, Sarika HL, Alevizaki CC, Papamichael C, Philippou G, Anastasiou EA, Lekakis JP, Mavrikakis M (2003) The androgen receptor gene CAG polymorphism is associated with the severity of coronary artery disease in men. Clin Endocrinol (Oxf) 59:749–755
Zitzmann M, Gromoll J, von Eckardstein A, Nieschlag E (2003) The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men. Diabetologia 46:31–39
Möhlig M, Arafat AM, Osterhoff MA, Isken F, Weickert MO, Spranger J, Pfeiffer AF, Schöfl C (2011) Androgen receptor CAG repeat length polymorphism modifies the impact of testosterone on insulin sensitivity in men. Eur J Endocrinol 164:1013–1018
Stanworth RD, Kapoor D, Channer KS, Jones TH (2008) Androgen receptor CAG repeat polymorphism is associated with serum testosterone levels, obesity and serum leptin in men with type 2 diabetes. Eur J Endocrinol 159:739–746
Rodríguez-González G, Ramírez-Moreno R, Pérez P, Bilbao C, López-Ríos L, Díaz-Chico JC, Lara PC, Serra-Majem L, Chirino R, Díaz-Chico BN (2009) The GGN and CAG repeat polymorphisms in the exon-1 of the androgen receptor gene are, respectively, associated with insulin resistance in men and with dyslipidemia in women. J Steroid Biochem Mol Biol 113:202–208
Skjaerpe PA, Giwercman YL, Giwercman A, Svartberg J (2010) Androgen receptor gene polymorphism and the metabolic syndrome in 60–80 years old Norwegian men. Int J Androl 33:500–506
Gustafson DR, Wen MJ, Koppanati BM (2003) Androgen receptor gene repeats and indices of obesity in older adults. Int J Obes Relat Metab Disord 27:75–81
Ponce-González JG, Guadalupe-Grau A, Rodríguez-González FG, Dorado C, Olmedillas H, Fuentes T, Rodríguez-García L, Díaz-Chico BN, Calbet JA (2012) Androgen receptor gene polymorphisms and the fat-bone axis in young men and women. J Androl 33:644–650
Ponce-González JG, Rodríguez-Garcia L, Losa-Reyna J, Guadalupe-Grau A, Rodriguez-Gonzalez FG, Díaz-Chico BN, Dorado C, Serrano-Sanchez JA, Calbet JA (2015) Androgen receptor gene polymorphism influence fat accumulation: a longitudinal study from adolescence to adult age. Scand J Med Sci Sports. doi: 10.1111/sms.12587
Delli Muti N, Agarwal A, Buldreghini E, Gioia A, Lenzi A, Boscaro M, Balercia G (2014) Have androgen receptor gene CAG and GGC repeat polymorphisms an effect on sperm motility in infertile men? Andrologia 46:564–569
Tirabassi G, Chelli FM, Ciommi M, Lenzi A, Balercia G (2016) Influence of the hypothalamic-pituitary-adrenal axis dysregulation on the metabolic profile of patients affected by diabetes mellitus-associated late onset hypogonadism. Nutr Metab Cardiovasc Dis 26:53–59
Tirabassi G, Delli Muti N, Gioia A, Biagioli A, Lenzi A, Balercia G (2014) Effects of testosterone replacement therapy on bone metabolism in male post-surgical hypogonadotropic hypogonadism: focus on the role of androgen receptor CAG polymorphism. J Endocrinol Invest 37:393–400
Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502
Vermeulen A, Verdonck L, Kaufman JM (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666–3672
Faloia E, Tirabassi G, Canibus P, Boscaro M (2009) Protective effect of leg fat against cardiovascular risk factors in obese premenopausal women. Nutr Metab Cardiovasc Dis 19:39–44
Ferlin A, Bartoloni L, Rizzo G, Roverato A, Garolla A, Foresta C (2004) Androgen receptor gene CAG and GGC repeat lengths in idiopathic male infertility. Mol Hum Reprod 10:417–421
Lundin KB, Giwercman A, Dizeyi N, Giwercman YL (2007) Functional in vitro characterisation of the androgen receptor GGN polymorphism. Mol Cell Endocrinol 264:184–187
Gao T, Marcelli M, McPhaul MJ (1996) Transcriptional activation and transient expression of the human androgen receptor. J Steroid Biochem Mol Biol 59:9–20
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest. No external funding, apart from the support of the Polytechnic University of Marche, was available for this study.
Statement of human and animal rights
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional or national research committee, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
For this type of study, formal consent is not required.
Rights and permissions
About this article
Cite this article
Tirabassi, G., Cutini, M., Beltrami, B. et al. Androgen receptor GGC repeat might be more involved than CAG repeat in the regulation of the metabolic profile in men. Intern Emerg Med 11, 1067–1075 (2016). https://doi.org/10.1007/s11739-016-1479-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-016-1479-6